Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid‐low rectal cancer. Issue 2 (28th September 2021)

• Record Type: Journal Article
• Authors: Valadão, Marcus; Cesar, Daniel; Véo, Carlos Augusto Rodrigues; Araújo, Rodrigo Otávio; do Espirito Santo, Gilmar Ferreira; Oliveira de Souza, Rafael; Aguiar, Samuel; Ribeiro, Reitan; de Castro Ribeiro, Héber Salvador; de Souza Fernandes, Paulo Henrique; Oliveira, Alexandre Ferreira
• Is Part Of: Journal of surgical oncology. Volume 125:Issue 2(2022)
• Page Start: 194
• Page End: 216
• Publication Date: 2021-09-28
• Subjects: practice guideline -- rectal cancer -- surgery -- treatment; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.26676
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: Background: Colorectal cancer (CRC) is the third leading cause of cancer in North America, Western Europe, and Brazil, and represents an important public health problem. It is estimated that approximately 30% of all the CRC cases correspond to tumors located in the rectum, requiring complex multidisciplinary treatment. In an effort to provide surgeons who treat rectal cancer with the most current information based on the best evidence in the literature, the Brazilian Society of Surgical Oncology (SBCO) has produced the present guidelines for rectal cancer treatment that is focused on the main topics related to daily clinical practice. Objectives: The SBCO developed the present guidelines to provide recommendations on the main topics related to the treatment of mid‐low rectal cancer based on current scientific evidence. Methods: Between May and June 2021, 11 experts in CRC surgery met to develop the guidelines for the treatment of mid‐low rectal cancer. A total of 22 relevant topics were disseminated among the participants. The methodological quality of a final list with 221 sources was evaluated, all the evidence was examined and revised, and the treatment guideline was formulated by the 11‐expert committee. To reach a final consensus, all the topics were reviewed via a videoconference meeting that was attended by all 11 of the experts. Results: The prepared guidelines contained 22 topics considered to be highly relevant in the treatment of mid‐low rectal cancer, covering subjects related to the tests required for staging, surgical technique‐related aspects, recommended measures to reduce surgical complications, neoadjuvant strategies, and nonoperative treatments. In addition, a checklist was proposed to summarize the important information and offer an updated tool to assist surgeons who treat rectal cancer provide the best care to their patients. Conclusion: These guidelines summarize concisely the recommendations based on the most current scientific evidence on the most relevant aspects of the treatment of mid‐low rectal cancer and are a practical guide that can help surgeons who treat rectal cancer make the best therapeutic decision.